Evidence map›Paper›PMID 37441256›Full record

ArticleNanoscale advances2023

Synthesis and properties of novel type I photosensitizer polycyclic amide.

Kui Wang, Tao Ye, Haoyang Du, Xiangyu Jin, Xiaofen Yi, Huiying Gao, Yuan Zhang, Wei Dong, Shihui Liu, Jing Guan and 2 more

Abstract read
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kui WangDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.ORCID https://orcid.org/0009-0004-7615-1902
Tao YeDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Haoyang DuDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Xiangyu JinDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Xiaofen YiDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Huiying GaoDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Yuan ZhangDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Wei DongDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Shihui LiuMIIT Key Laboratory of Critical Materials Technology for New Energy Conversion and Storage, School of Chemistry and Chemical Engineering, Harbin Institute of Technology Harbin China.ORCID https://orcid.org/0000-0002-6827-9357
Jing GuanDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Feng LinDepartment of Organic Chemistry, College of Pharmacy, Harbin Medical University Harbin China guanjing@ems.hrbmu.edu.cn xiaolin_linfeng@126.com.
Debin XiaMIIT Key Laboratory of Critical Materials Technology for New Energy Conversion and Storage, School of Chemistry and Chemical Engineering, Harbin Institute of Technology Harbin China.ORCID https://orcid.org/0000-0002-2658-2577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we have designed and synthesized a novel type-I photosensitizer (PhPA)

Identifiers

PMID37441256
PMCPMC10334370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.